Effects of 17β-estradiol and progesterone on the adhesion of human monocyticthp-1 cells to human female endothelial cells exposed to minimally oxidized ldl

Gynecologic and Obstetric Investigation

Volumn 44, Issue 1, 1997, Pages 47-52

  Suzuki, Akihiko ^a   Mizimo, Kiniio ^a   Asada, Yoshimasa ^a   Ino, Yasushi ^a   Kuwayama, Tomoyuki ^a   Okada, Mayumi ^a   Mizutani, Shigehiko ^a   Tomoda, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

17 Estradiol; Endothelial cells; Hormone replacement therapy; Minimally oxidized low density lipoprotein; Monocyte adhesion; Progesterone

Indexed keywords

ANTIESTROGEN; ESTRADIOL; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROGESTERONE; TAMOXIFEN;

ACUTE MONOCYTIC LEUKEMIA; ADULT; AORTA; ARTICLE; CELL ADHESION; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; FEMALE; HUMAN; MONOCYTE; NORTHERN BLOTTING; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ATHEROSCLEROSIS; CASE REPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HORMONE SUBSTITUTION; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AORTA; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; LIPOPROTEINS, LDL; MONOCYTES; PROGESTERONE; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030610357     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291408     Document Type: Article

References (36)

1. Fischcr-Dzoga K, Wissler RW. Vesselinovitch D: The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipémie serum. Exp Mol Pathol 1983; 39:355-363.
2. Adams MR, Kaplan JR. Manuck SB, Koritnik DR, Parkes JS. Wolfe MS, Clarkson TB: Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-1057.
3. Gruchow HW. Anderson AJ, Barboriak JJ, So-bocinski KA: Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954-963.
4. Sullivan JM, Van der Zwaag R, Lcmp GF, Hughs JP, Maddock V, Kroctz FW, Ramana-than KB, Mirvis DM: Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108:358-363.
5. Barret-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 1991:265: 1861-1867.
6. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
7. Rosenfeld ME, Tsukada T, Gown AM, Ross R: Fatty streak initiation in Watanabe heritable hyperlipémie and comparably hypercholestérolémie fat-fed rabbits. Arteriosclerosis 1987;7: 9-23.
8. Steinberg D, Parthasarathy S, Carcw T, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of LDL that increase its atherogenicity. N Engl J Med 1989;320:915-924.
9. Berliner JA, Territo MC, Sevanian A, Ramin S. Kim JA, Bamshad B, Estcrson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266.
10. Frostegard J, Haegarstrand A, Gidlund M, Nilsson J: Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 1991:90:119-126.
11. Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: LDL undergoes oxidative modification in vivo. Proc Natl Acad Sei USA 1991;86:1372-1380.
12. Colburn P, Buonassisi V: Estrogen-binding sites in endothelial cell cultures. Science 1978; 201:817-819.
13. Alexander JJ, Hoenig M. Graham D, Imbembo A: Effect of estradiol on low density lipoprotein uptake by bovine aortic endothelial cells. J Surg Rec 1989;46:537-542.
14. Capsini D, Bivosa A, Patema S, Valenza M. Albiero R: Oestrogen binding sites in fresh aortic tissue. Int J Tissue React 1987;9:393-398.
15. Shanker G, Sorci-Thomas M. Register TC, Adams MR: The inducible expression of THP-1 cell interleukin-1 mRNA: Effects of estrogen on differential response to phorbol ester and lipo-polysaccharide. Lymphokinc Cytokine Res 1994;13:1-7.
16. Shanker G, Sorci-Thomas M, Adams MR: Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocytc/macrophages. LifcSci 1995:56:499-507.
17. Lammli UK: Cleavage of structural proteins during the assembly of the head of bacterio-phageT4. Nature 1970;227:680-685.
18. Hashimoto M, Nakumura T, Inoue S, Kondo T, Yamada R, Eto Y, Sugino H, Muramatsu M: Follistatin is a developmentally regulated cytokine in neural differentiation. J Biol Chem 1992;267:7203-7206.
19. Koike S, Sasaki M, Muramatsu M: Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 1987; 15: 2499-2513.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
21. Dousset N, Negre-Salvayre A, Lopez M, Sal-vayre R, Douste-Blazy L: Ultraviolet-treated lipoproteins as a model for the study of the biological effects of lipid peroxides on cultured cell. I. Chemical modifications of ultraviolet-treated low density lipoproteins. Biochim Bio-physActa 1990;1045:219-223.
22. Negre-Salvayre A, Pieraggi MT, Mabile L, Sal-vayre R: Protective effect of 17p-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:207-217.
23. Yagi K: A simple fluorometric assay for lipid peroxide in blood plasma. Biochem Med 1976; 15:212-216.
24. Jordan VC: Biochemical pharmacology of antiestrogen action. Pharmacol Rev 1984;36: 245-257.
25. Lin AL, McGill HC, Shain SA: Hormone receptors of the baboon cardiovascular system: Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res 1982;50:610-616.
26. Ingegno MD, Money SR. Thelmo W, Greene GL, Davidian M, Jaffe BM, Pertschuk LP: Progesterone receptors in the human heart and great vessels. Lab Invest 1988;59:353-356.
27. Proug SG, Aksel S, Wiebe RH, Shepherd J: Continuous estrogen/progestin therapy in menopause. Am J Obstet Gynecol 1987:157: 1449-1453.
28. Moyer DL, de Lignières B, Driguez P. Pez JP: Prevention of endometrial hyperplasia by progesterone during long-term estrogen replacement: Influence of bleeding pattern and secretory changes. Fertil Steril 1993;59:992-997.
29. Poston RN, Haaskard DO, Coucher JR. Gall NP, Johoson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-673.
30. Wood KM, Cadogan MD. Ramshaw AL, Pa-rums DV: The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993;22:437-444.
31. O’Brian KD, Allen MD, McDonald TO, Chait A, Harian JM, Fishbein D, McCarty J, Ferguson M, Hudkins K. Benjamin CD, Lobb R, Aipers CE: Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92:945-951.
32. Bevilacqua MP: Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767-804.
33. Springer TA: Adhesion receptors of the immune system. Nature 1993;346:425-434.
34. Haller H, Schaper D, Ziegler W, Philipp S, Kuhlmann M, Distler A, Luft FC: Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension 1995;25:511-516.
35. Cybulsky ML, Fries JW, Williams AJ, Sultan P, Eddy R, Bayers M, Shows T, Gimbrone MA, Collins T: Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sei USA 1991;88:7859-7863.
36. Nakai K, Itoh C, Hotta K, Itoh T, Yoshizumi M. Hiramori K: Estradiol-17ß regulates the induction of VCAM-1 mRNA expression by interleukin-lß in human umbilical vein endothelial cells. Life Sei 1994;54:221-227.